Biohaven Pharmaceutical Hold
13F holders, Q1 2024 (March 31)2holders
$54.69avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Biohaven Pharmaceutical Hold in their 13F filings. The largest holders were Knoll Capital Management, LLC ($26.8M) and Birchview Capital, LP ($403K).
- Company
- Biohaven Pharmaceutical Hold
- CUSIP
- G11196105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Knoll Capital Management, LLC | 16.69% | No change | 490,422 | $26.8M |
| Birchview Capital, LP | 0.33% | No change | 7,365 | $403K |
"% of holder's portfolio" is BIOHAVEN PHARMACEUTICAL HOLD's weight in each manager's 13F, not the share of Biohaven Pharmaceutical Hold the manager owns.